Cargando…

A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma

BACKGROUND: Ocular infections with Chlamydia trachomatis serovars A–C cause the neglected tropical disease trachoma. As infection does not confer complete immunity, repeated infections are common, leading to long-term sequelae such as scarring and blindness. Here, we apply a systems serology approac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barton, Amber, Rosenkrands, Ida, Pickering, Harry, Faal, Nkoyo, Harte, Anna, Joof, Hassan, Makalo, Pateh, Ragonnet, Manon, Olsen, Anja Weinreich, Bailey, Robin L., Mabey, David C. W., Follmann, Frank, Dietrich, Jes, Holland, Martin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242090/ https://www.ncbi.nlm.nih.gov/pubmed/37287960 http://dx.doi.org/10.3389/fimmu.2023.1178741

Ejemplares similares

Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia
por: Migchelsen, Stephanie J., et al.
Publicado: (2017)

Longitudinal changes in tear cytokines and antimicrobial proteins in trachomatous disease
por: Barton, Amber, et al.
Publicado: (2023)

Conjunctival FOXP3 Expression in Trachoma: Do Regulatory T Cells Have a Role in Human Ocular Chlamydia trachomatis Infection?
por: Faal, Nkoyo, et al.
Publicado: (2006)

Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma
por: Pickering, Harry, et al.
Publicado: (2019)

Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?
por: Andreasen, Aura A., et al.
Publicado: (2008)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies
por: Migchelsen, Stephanie J., et al.
Publicado: (2017)

Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

A flow cytometry‐based assay to determine the phagocytic activity of both clinical and nonclinical antibody samples against Chlamydia trachomatis
por: Grasse, Marco, et al.
Publicado: (2018)

A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars
por: Olsen, Anja Weinreich, et al.
Publicado: (2021)

Publisher Correction: A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars
por: Olsen, Anja Weinreich, et al.
Publicado: (2022)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities
por: Burton, Matthew J., et al.
Publicado: (2010)

Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection
por: Pickering, Harry, et al.
Publicado: (2017)

Profiling and validation of individual and patterns of Chlamydia trachomatis-specific antibody responses in trachomatous trichiasis
por: Pickering, Harry, et al.
Publicado: (2017)

Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data
por: Goncalves, Adriana, et al.
Publicado: (2016)

Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis
por: Olsen, Anja Weinreich, et al.
Publicado: (2017)

Conjunctival MicroRNA Expression in Inflammatory Trachomatous Scarring
por: Derrick, Tamsyn, et al.
Publicado: (2013)

The conjunctival microbiome in health and trachomatous disease: a case control study
por: Zhou, Yanjiao, et al.
Publicado: (2014)

The utility of serology for elimination surveillance of trachoma
por: Pinsent, Amy, et al.
Publicado: (2018)

Serology for Trachoma Surveillance after Cessation of Mass Drug Administration
por: Martin, Diana L., et al.
Publicado: (2015)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger
por: Kim, Jessica S., et al.
Publicado: (2019)

SEROLOGIC STRAIN DIFFERENTIATION IN TRACHOMA
por: Nichols, Roger L., et al.
Publicado: (1964)

Serological Measures of Trachoma Transmission Intensity
por: Martin, Diana L., et al.
Publicado: (2015)

Monitoring transmission intensity of trachoma with serology
por: Tedijanto, Christine, et al.
Publicado: (2023)

Monitoring transmission intensity of trachoma with serology
por: Tedijanto, Christine, et al.
Publicado: (2023)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

Responses of the putative trachoma vector, Musca sorbens, to volatile semiochemicals from human faeces
por: Robinson, Ailie, et al.
Publicado: (2020)

Epidemiology and control of trachoma: systematic review
por: Hu, Victor H, et al.
Publicado: (2010)

Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With Chlamydia trachomatis
por: Nguyen, Nina Dieu Nhien Tran, et al.
Publicado: (2021)

The Global Burden of Trachoma: A Review
por: Burton, Matthew J., et al.
Publicado: (2009)

In Vivo Confocal Microscopy in Scarring Trachoma
por: Hu, Victor H., et al.
Publicado: (2011)

Quantitative Protein Profiling of Chlamydia trachomatis Growth Forms Reveals Defense Strategies Against Tryptophan Starvation
por: Østergaard, Ole, et al.
Publicado: (2016)

Targeting Antibiotics to Households for Trachoma Control
por: Blake, Isobel M., et al.
Publicado: (2010)

The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children
por: Pickering, Harry, et al.
Publicado: (2022)

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
por: Edwards, Tansy, et al.
Publicado: (2014)

The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control
por: Gambhir, Manoj, et al.
Publicado: (2009)

Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district
por: Odonkor, Michelle, et al.
Publicado: (2021)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

When Can Antibiotic Treatments for Trachoma Be Discontinued? Graduating Communities in Three African Countries
por: Ray, Kathryn J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6rr4trv6ulqi3ocatetkm1jqih